Suda Y, Fujiki T
Division of Abdominal Surgery, Saitama Cancer Center Hospital, Japan.
Gan To Kagaku Ryoho. 1996 Aug;23(9):1191-6.
Although biliary excretion of Etoposide is thought to be one of the main excretory routes, less investigation has been performed in human because of the clinical difficulties of bile collection. In the present study, the biliary and pancreatic excretion of Etoposide was examined through the hepaticus- or pancreaticus drainage in two pancreatoduodenectomized patients. The drug (95 mg) was infused for 30 min. Blood, bile and pancreatic juice were taken consecutively during and after infusion. Etoposide in the samples was measured as an unchanged type by HPLC. Etoposide was detected in the bile at the same level or more of the blood, their correlation being significant during the observation period. Recovery of the unchanged drug from the hepatic bile in the present series was 2.7-3.0% during the period of 3.5 hrs. And total recovery was estimated as 3.5-4.0% from AUC of the further extended concentration curve. Pancreatic excretion of Etoposide was minimum, its ratio with blood concentration being 2-3%. Recovery for 3.5 hrs. was less than 0.02%. From the data obtained, the biliary excretion of Etoposide was discussed together with its metabolites.
虽然依托泊苷的胆汁排泄被认为是主要排泄途径之一,但由于胆汁采集存在临床困难,在人体上进行的研究较少。在本研究中,通过对两名接受胰十二指肠切除术患者进行肝或胰引流,检测了依托泊苷的胆汁和胰腺排泄情况。将药物(95毫克)输注30分钟。在输注期间和输注后连续采集血液、胆汁和胰液。通过高效液相色谱法将样品中的依托泊苷作为原形进行测定。在胆汁中检测到的依托泊苷与血液中的水平相同或更高,在观察期内它们之间的相关性显著。在本系列中,在3.5小时内从肝胆汁中回收的原形药物为2.7% - 3.0%。根据进一步延长的浓度曲线的曲线下面积估计总回收率为3.5% - 4.0%。依托泊苷的胰腺排泄量极少,其与血药浓度的比值为2% - 3%。3.5小时的回收率低于0.02%。根据获得的数据,对依托泊苷的胆汁排泄及其代谢产物进行了讨论。